Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients

Publication

Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients

Journal Paper/Review - Jul 13, 2018

Quteineh Lina, Mohacsi Paul, Dufour Jean-François, Soccal Paola M, Kutalik Zoltán, Marques-Vidal Pedro, Vollenweider Peter, Recher Mike, Hess Christoph, Pascual Manuel, Eap Chin B, Steiger Jürg, Van Delden Christian, Wójtowicz Agnieszka, Bochud Pierre-Yves, Crettol Severine, Vandenberghe Frederik, Venetz Jean-Pierre, Manuel Oriol, Golshayan Déla, Lehmann Roger, Mueller Nicolas J, Binet Françoise-Isabelle, Swiss Transplant Cohort Study

Citation

Quteineh L, Mohacsi P, Dufour J, Soccal P, Kutalik Z, Marques-Vidal P, Vollenweider P, Recher M, Hess C, Pascual M, Eap C, Steiger J, Van Delden C, Wójtowicz A, Bochud P, Crettol S, Vandenberghe F, Venetz J, Manuel O, Golshayan D, Lehmann R, Mueller N, Binet F, Swiss Transplant Cohort Study. Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients. Am J Transplant 2018; 19:238-246.

Type

Journal Paper/Review (English)

Journal

Am J Transplant 2018; 19

Publication Date

Jul 13, 2018

Issn Electronic

1600-6143

Pages

238-246

Brief description/objective

New-onset diabetes mellitus after transplantation (NODAT) is a complication following solid organ transplantation (SOT) and may be related to immune or inflammatory responses. We investigated whether single nucleotide polymorphisms (SNPs) within 158 immune- or inflammation-related genes contribute to NODAT in SOT recipients. The association between 263 SNPs and NODAT was investigated in a discovery sample of SOT recipients from the Swiss Transplant Cohort Study (STCS, n = 696). Positive results were tested in a first STCS replication sample (n = 489) and SNPs remaining significant after multiple test corrections were tested in a second SOT replication sample (n = 156). Associations with diabetic traits were further tested in several large general population-based samples (n > 480 000). Only SP110 rs2114592C>T remained associated with NODAT in the STCS replication sample. Carriers of rs2114592-TT had 9.9 times (95% confidence interval [CI]: 3.22-30.5, P = .00006) higher risk for NODAT in the combined STCS samples (n = 1184). rs2114592C>T was further associated with NODAT in the second SOT sample (odds ratio: 4.8, 95% CI: 1.55-14.6, P = .006). On the other hand, SP110 rs2114592C>T was not associated with diabetic traits in population-based samples, suggesting a specific gene-environment interaction, possibly due to the use of specific medications (ie, immunosuppressants) in transplant patients and/or to the illness that may unmask the gene effect.